Bilateral peripheral infiltrates refractory to immunosuppressants were diagnosed as autoimmune pulmonary alveolar proteinosis and improved by inhalation of granulocyte/macrophage-colony stimulating factor
- PMID: 22790136
- DOI: 10.2169/internalmedicine.51.6093
Bilateral peripheral infiltrates refractory to immunosuppressants were diagnosed as autoimmune pulmonary alveolar proteinosis and improved by inhalation of granulocyte/macrophage-colony stimulating factor
Abstract
A 55-year-old non-smoking woman was admitted to our hospital for re-evaluation of unimproved peripheral ground-glass opacities despite prednisolone and cyclosporine treatment. She was diagnosed with autoimmune pulmonary alveolar proteinosis (PAP) based on transbronchial lung biopsy and granulocyte/macrophage colony-stimulating factor (GM-CSF) antibody testing. GM-CSF inhalation therapy markedly improved the opacities. Bilateral, centrally located lung opacities are typical in PAP, however 10 PAP cases with peripheral infiltration were reported in Japan recently, of which GM-CSF antibody was positive in six. To avoid inappropriate immunosuppressant treatment, PAP should be considered in the differential diagnosis of such peripheral opacities. GM-CSF antibody might be useful for diagnosis.
Similar articles
-
Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis.Tohoku J Exp Med. 2017 Sep;243(1):77-83. doi: 10.1620/tjem.243.77. Tohoku J Exp Med. 2017. PMID: 28966213
-
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216. N Engl J Med. 2019. PMID: 31483963 Clinical Trial.
-
Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.BMC Pulm Med. 2020 Apr 6;20(1):84. doi: 10.1186/s12890-020-1110-5. BMC Pulm Med. 2020. PMID: 32252718 Free PMC article.
-
GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm.Intern Med. 2017;56(4):435-439. doi: 10.2169/internalmedicine.56.6920. Epub 2017 Feb 15. Intern Med. 2017. PMID: 28202867 Free PMC article. Review.
-
Pulmonary Alveolar Proteinosis Syndrome.Clin Chest Med. 2016 Sep;37(3):431-40. doi: 10.1016/j.ccm.2016.04.006. Epub 2016 Jun 17. Clin Chest Med. 2016. PMID: 27514590 Free PMC article. Review.
Cited by
-
Effect of formulation on the stability and aerosol performance of a nebulized antibody.MAbs. 2014;6(5):1347-55. doi: 10.4161/mabs.29938. Epub 2014 Oct 30. MAbs. 2014. PMID: 25517319 Free PMC article.
-
Autoimmune pulmonary alveolar proteinosis presenting peripheral ground-glass opacities.Respirol Case Rep. 2018 Nov 13;7(1):e00385. doi: 10.1002/rcr2.385. eCollection 2019 Jan. Respirol Case Rep. 2018. PMID: 30459948 Free PMC article.
-
Autoimmune Pulmonary Alveolar Proteinosis.Am J Respir Crit Care Med. 2022 May 1;205(9):1016-1035. doi: 10.1164/rccm.202112-2742SO. Am J Respir Crit Care Med. 2022. PMID: 35227171 Free PMC article.
-
Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review.Front Med (Lausanne). 2025 May 8;12:1552566. doi: 10.3389/fmed.2025.1552566. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40406404 Free PMC article. Review.
-
Autoimmune pulmonary alveolar proteinosis with features similar to nonspecific interstitial pneumonia.Respir Med Case Rep. 2022 Feb 3;36:101591. doi: 10.1016/j.rmcr.2022.101591. eCollection 2022. Respir Med Case Rep. 2022. PMID: 35535320 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials